Andrew H Miller
Emory University · Emory Winship Cancer Institute · Emory University School of Medicine, Department of Psychiatry and Behavioral Sciences
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Andrew H Miller as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:27 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07608796 · JAK Signaling in Depression and Cognition in Male Football PlayersEmory University · recruiting · Depressive Symptoms, Cognitive Symptom · principal investigator
- Ph2NCT07209267 · Baricitinib Curative Repression of HIV-1Emory University · not yet recruiting · HIV Infection, HIV · principal investigator
- Ph2NCT05849038 · Inflammation and Depression in People With HIVEmory University · recruiting · HIV, Depression, Anhedonia · principal investigator
- Ph4NCT03004443 · Inflammation-Induced CNS Glutamate Changes in DepressionEmory University · terminated · Depression · principal investigator
- Ph4NCT02796755 · Effects of Riluzole on CNS Glutamate and Fatigue in Breast Cancer Survivors With High InflammationEmory University · completed · Inflammation, Fatigue · principal investigator
- N/ANCT02421978 · Inflammation-Induced CNS Glutamate During Breast Cancer TreatmentEmory University · completed · Breast Cancer · principal investigator
- Ph2NCT01740323 · Phase II Study of Curcumin vs Placebo for Chemotherapy-Treated Breast Cancer Patients Undergoing RadiotherapyAndrew H Miller · completed · Breast Cancer · principal investigator
- N/ANCT01426997 · Phenotype Depression StudyEmory University · completed · Major Depressive Disorder · principal investigator
- Ph4NCT00463580 · A Study of Infliximab for Treatment Resistant Major DepressionEmory University · completed · Depression · principal investigator
- N/ANCT00209118 · Paroxetine for the Treatment of Interferon Related Side Effects for Hepatitis CEmory University · completed · Hepatitis C, Depression, Interferon-alpha Associated Side Effects · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:27 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 5 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- JAK Signaling as a Mechanism of Inflammation-related Reward and Motor Circuit Deficits in DepressionR01MH140180 · NIMH · EMORY UNIVERSITY · fiscal years 2025 to 2026 · $627,566 awarded in 2026Same name and institution; not confirmed by an ID
- The Role of Inflammation in CNS Mechanisms of Anhedonia and Psychomotor Slowing in Depressed PWH as Determined using a Next Generation TNF AntagonistR01MH128872 · NIMH · EMORY UNIVERSITY · fiscal years 2021 to 2026 · $618,864 awarded in 2026Grant number is on one of their registry trials
- Emory Psychiatry Clinical Scientist Training Program (CSTP)R25MH101079 · NIMH · EMORY UNIVERSITY · fiscal years 2014 to 2025 · $199,392 awarded in 2025Same name and institution; not confirmed by an ID
- Using Human iPSC Models to Determine the Mechanism of Inflammation-Induced Disruption of Dopamine NeurotransmissionR21MH132012 · NIMH · EMORY UNIVERSITY · fiscal years 2022 to 2023 · $195,625 awarded in 2023Same name and institution; not confirmed by an ID
- Effects of Bupropion versus Escitalopram on Reward Circuitry and Motivational Deficits in Patients with Major Depression and Increased Inflammation and AnhedoniaR21MH121891 · NIMH · EMORY UNIVERSITY · fiscal years 2020 to 2021 · $234,000 awarded in 2021Same name and institution; not confirmed by an ID
- Inflammation-Induced CNS Glutamate Changes in DepressionR01MH112076 · NIMH · EMORY UNIVERSITY · fiscal years 2016 to 2020 · $408,239 awarded in 2020Grant number is on one of their registry trials
- Inflammation-Induced CNS Glutamate During Breast Cancer TreatmentR21MH105897 · NIMH · EMORY UNIVERSITY · fiscal years 2015 to 2016 · $234,000 awarded in 2016Grant number is on one of their registry trials
- Phenotyping Major Depression with Increased InflammationR01MH087604 · NIMH · EMORY UNIVERSITY · fiscal years 2010 to 2014 · $427,498 awarded in 2014Grant number is on one of their registry trials
- Predictors and Targets of Response to Cytokine Antagonism in DepressionR03MH100273 · NIMH · EMORY UNIVERSITY · fiscal years 2013 to 2014 · $78,000 awarded in 2014Same name and institution; not confirmed by an ID
- Caregiver Stress: Interventions to Promote Health and WellbeingP01NR011587 · NINR · EMORY UNIVERSITY · fiscal years 2009 to 2013 · $595,202 awarded in 2013Same name and institution; not confirmed by an ID
- Dopaminergic Mechanisms of Cytokine-Induced Behavioral ChangeR01MH083746 · NIMH · EMORY UNIVERSITY · fiscal years 2009 to 2012 · $383,625 awarded in 2012Same name and institution; not confirmed by an ID
- IL-2 Neuropsychiatric Symptoms: Mechanisms, PreventionR01MH071580 · NIMH · EMORY UNIVERSITY · fiscal years 2010 · $334,267 awarded in 2010Same name and institution; not confirmed by an ID
- Neuroimmune Mechanisms of Glucocorticoid ResistanceR01MH075102 · NIMH · EMORY UNIVERSITY · fiscal years 2006 to 2010 · $228,787 awarded in 2010Same name and institution; not confirmed by an ID
- Annual Mentoring Program in PsychoNeuroImmunology ResearchR13CA139766 · NCI · EMORY UNIVERSITY · fiscal years 2009 · $26,000 awarded in 2009Same name and institution; not confirmed by an ID
- Fronto-Striatal Dysfunction in IFNa-Induced DepressionR01MH067990 · NIMH · EMORY UNIVERSITY · fiscal years 2004 to 2008 · $261,130 awarded in 2008Same name and institution; not confirmed by an ID
- HIV/AIDS Clinical Research Training ProgramT32MH020018 · NIMH · EMORY UNIVERSITY · fiscal years 2002 to 2008 · $152,403 awarded in 2008Same name and institution; not confirmed by an ID
- Pathology and Treatment of Cytokine-Induced DepressionK05MH069124 · NIMH · EMORY UNIVERSITY · fiscal years 2004 to 2008 · $116,932 awarded in 2008Same name and institution; not confirmed by an ID
- Pathophysiology of IFN-alpha-induced Sleep DisturbancesR01HL073921 · NHLBI · EMORY UNIVERSITY · fiscal years 2004 to 2008 · $290,143 awarded in 2008Same name and institution; not confirmed by an ID
- PsychoimmunologyP50MH058922 · NIMH · EMORY UNIVERSITY · fiscal years 2004 to 2008 · $166,765 awarded in 2008Same name and institution; not confirmed by an ID
- Cytokine Induced DepressionU19MH069056 · NIMH · EMORY UNIVERSITY · fiscal years 2003 to 2007 · $237,616 awarded in 2007Same name and institution; not confirmed by an ID
- Dev Proj 4: Identifying IFN-alpha-Induced Microglial Activation Using...P20CA134223 · NCI · EMORY UNIVERSITY · fiscal years 2007 · $38,187 awarded in 2007Same name and institution; not confirmed by an ID
- Paroxetine Depression PreventionM01RR000039 · NCRR · EMORY UNIVERSITY · fiscal years 2004 · $5,712 awarded in 2004Same name and institution; not confirmed by an ID
- ADRENAL STEROID--IMMUNE INTERACTIONSK02MH000680 · NIMH · EMORY UNIVERSITY · fiscal years 1994 to 2003 · $118,487 awarded in 2003Same name and institution; not confirmed by an ID
- IFN ALPHA-INDUCED DEPRESSIONR01MH060723 · NIMH · EMORY UNIVERSITY · fiscal years 2000 to 2003 · $342,000 awarded in 2003Same name and institution; not confirmed by an ID
- ADRENAL STEROID-IMMUNE INTERACTIONS IN VIRAL INFECTIONSR01MH047674 · NIMH · EMORY UNIVERSITY · fiscal years 1991 to 2002 · $322,515 awarded in 2002Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Meriva for treatment-induced inflammation and fatigue in women with breast cancerR21CA178603 · NCI · UNIVERSITY OF ARIZONA · PI THADDEUS PACE · fiscal years 2014 to 2015Named on NCT01740323
- Neurobiological and Behavioral Effects of Cytokine Antagonism in Major DepressionR21MH077172 · NIMH · EMORY UNIVERSITY · PI Charles Louise Raison · fiscal years 2008 to 2009Named on NCT00463580
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:27 UTC. The ranking covers the 200 most relevant of 32 PubMed records, and a shared surname and initials can bring in a namesake. All 32 on PubMed
- A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.JAMA Psychiatry · 20131,331 citationsRCR 46.9
- Paroxetine for the prevention of depression induced by high-dose interferon alfa.N Engl J Med · 2001787 citationsRCR 21.0
- Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions.Neuropsychopharmacology · 2002604 citationsRCR 14.9
- Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment.Biol Psychiatry · 2003368 citationsRCR 9.5
- Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy.Am J Psychiatry · 2003232 citationsRCR 5.9
- Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy.Neuropsychopharmacology · 2007198 citationsRCR 5.5
- Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment.Mol Psychiatry · 2009187 citationsRCR 5.4
- Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy.Brain Behav Immun · 2004181 citationsRCR 4.8
- Anterior cingulate activation and error processing during interferon-alpha treatment.Biol Psychiatry · 2005170 citationsRCR 4.5
- Interferon-alpha effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior.Mol Psychiatry · 2010147 citationsRCR 4.6